5 , 11 Dowsett et al 31 identified a strong trend in the benefit from tamoxifen therapy for patients with ER-negative/PR-positive tumors.
← all excerpts
Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
1
—
—